C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2001
12/06/2001	WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family
12/06/2001	WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
12/06/2001	US20010049830 Molecular farming
12/06/2001	US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections
12/06/2001	US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays
12/06/2001	US20010049119 Processes for making protein hydrolysates from animal peptone and for preserving mucosa
12/06/2001	US20010049107 Patient-specific library of antineoplastic antibodies or fragments; variable regions are linked, cloned into expression vectors, amplified; libraries transferred to other expression vectors without losing diversity
12/06/2001	US20010048928 Herpesvirus particles comprising fusion protein and their preparation and use
12/06/2001	US20010048922 Stimulating immune response to taregted antigen; binding
12/06/2001	CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
12/06/2001	CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
12/06/2001	CA2410754A1 Phosphorylated polypeptides and uses related thereto
12/06/2001	CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype
12/06/2001	CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof
12/06/2001	CA2410419A1 Improved methods of transfection
12/06/2001	CA2410084A1 Transporters and ion channels
12/06/2001	CA2410051A1 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes
12/06/2001	CA2409311A1 Regulators of apoptosis
12/05/2001	EP1160322A2 Human melanocyte stimulating hormone receptors
12/05/2001	EP1160256A2 Monoclonal antibody specific for beta-A4 peptide
12/05/2001	EP1160254A1 Human vanilloid receptor-like proteins
12/05/2001	EP1159432A1 Methods for generating and screening novel metabolic pathways
12/05/2001	EP1159422A1 Compositions and methods for the treatment of tumors
12/05/2001	EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
12/05/2001	EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/05/2001	EP1159417A2 Polynucleotides and proteins encoded thereby
12/05/2001	EP1159412A2 Composition, methods and reagents for the synthesis of a soluble form of human phex
12/05/2001	EP1159411A1 A NOVEL COMPLEX OF HUMAN KALLIKREIN 2 (hK2) AND PROTEASE INHIBITOR-6 (PI-6) IN PROSTATE TUMOR TISSUE AND METHODS OF USING THE COMPLEX
12/05/2001	EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
12/05/2001	EP1159299A1 Mammalian cytokines; related reagents and methods
12/05/2001	EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis
12/05/2001	EP1159287A1 50 human secreted proteins
12/05/2001	EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP0951563A4 A new eia test using non-dentured hiv antigen for early detection of hiv infection
12/05/2001	EP0948409A4 Apparatus for multi-well microscale synthesis
12/05/2001	EP0873363A4 Novel high affinity human antibodies to tumor antigens
12/05/2001	EP0769056B1 NON-SPLICING VARIANTS OF gp350/220
12/05/2001	EP0763114B1 Hepatitis g virus and molecular cloning thereof
12/05/2001	EP0763100A4 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies
12/05/2001	EP0663953B1 Phagemids coexpressing a surface receptor and a surface heterologous protein
12/05/2001	EP0651809B1 A family of map2 protein kinases
12/05/2001	EP0651804B1 Process for obtaining antibodies
12/05/2001	CN1325455A Enzymatic amidation of peptides
12/05/2001	CN1325447A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
12/05/2001	CN1325443A Glycosylated proteins having reduced allergenicity
12/05/2001	CN1325442A Endothelial cell proliferation inhibitors derived from human prothrombin
12/05/2001	CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof
12/05/2001	CN1325404A Low allergenic proteinvariants
12/05/2001	CN1324820A New human protein with the function of inhibiting cancer cell growth and its encoding sequence
12/05/2001	CN1324819A New human protein with the function of inhibiting tumor cell growth and its encoding sequence
12/05/2001	CN1075836C Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
12/04/2001	US6326527 Method for altering the nutritional content of plant seed
12/04/2001	US6326477 Nucleotide sequences coding polypeptide which maintains viability in genetically engineeered fungus; for use as a tool in controlled gene expression
12/04/2001	US6326472 Human receptor proteins; related reagents and methods
12/04/2001	US6326469 Megakaryocytic protein tyrosine kinases
12/04/2001	US6326464 Genetically engineered tumor suppressor protein; for use in the treatment of cancers; antiproliferative agents
12/04/2001	US6326462 Polypeptides exhibits lumazine synthase
12/04/2001	US6326351 Insecticides
12/04/2001	US6326350 Genetic engineering
12/04/2001	US6326181 Cell volume-regulated human kinase h-sgk
12/04/2001	US6326171 Hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same
12/04/2001	US6326170 Prokaryotic polynucleotides, polypeptides and their uses
12/04/2001	US6326165 Nucleotide sequences used for the detection of preferential basic helix loop helix genes; for detection of insectcide tolerant genes
12/04/2001	US6326162 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
12/04/2001	US6326159 Receptors for immune complexes
12/04/2001	US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect
12/04/2001	US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof
12/04/2001	US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses
12/04/2001	US6325998 Methods of treating disease using recombinant adeno-associated virus virions administered to muscle
12/04/2001	CA2238668C Novel enzyme catalyzing dephosphorylation
12/04/2001	CA2117581C Protocadherin, their antibodies and uses
12/04/2001	CA2110703C Process and culture medium for the production of cells infected by a multiple sclerosis associated virus
12/04/2001	CA2062729C Interferon purification process
12/04/2001	CA2027635C Erythropoietin isoforms
11/2001
11/29/2001	WO2001090395A1 A method for manufacturing highly-concentrated polyglutamic acid with additional supply of saccharides
11/29/2001	WO2001090389A2 Production of silk-like proteins in plants
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090355A1 Human sodium channel scn12a and scn8a
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090304A2 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001090194A2 Antibodies against particular forms of propsa and use thereof in immunoassays
11/29/2001	WO2001090192A2 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	WO2001090191A2 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS
11/29/2001	WO2001090182A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090151A2 Human receptor proteins; related reagents and methods
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090147A2 Long wavelength engineered fluorescent proteins
11/29/2001	WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
11/29/2001	WO2001089560A1 Inhibitors of viral infection
11/29/2001	WO2001062284A3 Novel method for down-regulation of amyloid
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040309A3 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use

1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1125